avapro has been researched along with Reperfusion Injury in 2 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakano, Y | 1 |
| Matoba, T | 1 |
| Tokutome, M | 1 |
| Funamoto, D | 1 |
| Katsuki, S | 1 |
| Ikeda, G | 1 |
| Nagaoka, K | 1 |
| Ishikita, A | 1 |
| Nakano, K | 1 |
| Koga, J | 1 |
| Sunagawa, K | 1 |
| Egashira, K | 1 |
| Meijer, P | 1 |
| Wouters, CW | 1 |
| Oyen, WJ | 1 |
| Boerman, OC | 1 |
| Scheffer, GJ | 1 |
| Smits, P | 1 |
| Rongen, GA | 1 |
1 trial available for avapro and Reperfusion Injury
| Article | Year |
|---|---|
Angiotensin II type 1 receptor blockade does not enhance apoptotic cell death during ischemia and reperfusion in humans in vivo.
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Annexin A5; Apoptosis; Biphenyl Compound | 2011 |
1 other study available for avapro and Reperfusion Injury
| Article | Year |
|---|---|
Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation.
Topics: Administration, Intravenous; Animals; Biphenyl Compounds; Cardiotonic Agents; Disease Models, Animal | 2016 |